Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

755
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
755
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.6K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.6K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

385
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
385
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

333
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
333
Nociception01:44

Nociception

29.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
29.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer.

JCO oncology practice·2026
Same author

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.

Clinical pharmacology and therapeutics·2025
Same author

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test.

Clinical pharmacology and therapeutics·2025
Same author

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.

Clinical pharmacology and therapeutics·2025
Same author

Understanding the Biology and Testing Techniques for Pharmacogenomics in Oncology: A Practical Guide for the Clinician.

JCO oncology practice·2024
Same author

Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2024

Related Experiment Video

Updated: Aug 24, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K

Integrating pharmacogenomics into precision pain management.

Jill Bates1, Jeffrey Fudin2, Jai N Patel3

  • 1Department of Veterans Affairs, Durham, NC, USA.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|October 21, 2022
PubMed
Summary

Pharmacogenomics (PGx) uses genetic information to guide pain medication selection and dosing. Applying Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines can improve pain management effectiveness and safety.

Keywords:
AnalgesicsNon-steroidal anti-inflammatory drugsOpioidsPharmacogenomicsPrecision pain management

More Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.3K
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

589

Related Experiment Videos

Last Updated: Aug 24, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.3K
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

589

Area of Science:

  • Pharmacogenomics
  • Clinical Pharmacology
  • Pain Management

Background:

  • Pain management shows significant variability in patient response.
  • Current analgesic therapies require improved clinical efficacy and safety profiles.
  • Pharmacogenomics (PGx) offers a pathway for personalized pain medication strategies.

Purpose of the Study:

  • To highlight the role of pharmacogenomics in optimizing pain pharmacotherapy.
  • To emphasize the clinical utility of Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for pain management.
  • To advocate for increased awareness and application of PGx in precision pain care.

Main Methods:

  • Review of existing pharmacogenomic data and Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines.
  • Focus on drug-gene interactions with high evidence levels applicable to pain medications.
  • Discussion of how PGx results can inform clinical prescribing decisions for analgesics.

Main Results:

  • Pharmacogenomic testing can guide the precise selection and dosing of pain medications.
  • Established CPIC guidelines provide actionable recommendations for integrating PGx into clinical practice.
  • Application of PGx can lead to improved treatment outcomes and reduced adverse events in pain management.

Conclusions:

  • Pharmacogenomics holds significant potential to personalize pain pharmacotherapy.
  • CPIC guidelines offer a robust framework for implementing PGx in clinical settings for pain management.
  • Integrating PGx into pain management strategies is crucial for enhancing patient care and safety.